Recombinant human endostatin (endostar) decreased recurrent ascites, pleural fluid and ascitic VEGF in a case of advanced mesothelioma
Xiaofeng Chen(Ningbo University), Renhua Guo(Sun Yat-sen University), Guoqian Ping(Jiangsu Province Hospital), Yongqian Shu(Jiangsu Province Hospital), Yongmei Yin(Nanjing Medical University), Yiqian Liu(Jiangsu Province Hospital), Oluf Dimitri Røe(Norwegian University of Science and Technology), Shidai Jin(Jiangsu Province Hospital), Keli Yan(Jiangsu Province Hospital)
Cited by 5
Related Papers
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|743
Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial
|The Lancet Respiratory Medicine|2020|508